NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) Reaches New 52-Week High – Here’s Why

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN)’s stock price reached a new 52-week high on Tuesday . The company traded as high as C$5.85 and last traded at C$5.83, with a volume of 244847 shares changing hands. The stock had previously closed at C$5.76.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on NWH.UN. Canadian Imperial Bank of Commerce lifted their target price on NorthWest Health Prop Real Est Inv Trust from C$5.50 to C$5.75 in a research report on Thursday, November 13th. Royal Bank Of Canada set a C$5.50 price objective on NorthWest Health Prop Real Est Inv Trust and gave the stock a “sector perform” rating in a report on Monday, November 24th. BMO Capital Markets increased their target price on NorthWest Health Prop Real Est Inv Trust from C$5.00 to C$6.00 in a research note on Thursday, November 13th. Finally, Scotiabank lifted their price target on shares of NorthWest Health Prop Real Est Inv Trust from C$6.50 to C$7.00 in a research note on Thursday, November 13th. One investment analyst has rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of C$6.00.

NorthWest Health Prop Real Est Inv Trust Stock Performance

The stock has a market cap of C$1.46 billion, a P/E ratio of 28.84, a price-to-earnings-growth ratio of 0.74 and a beta of 1.78. The company has a debt-to-equity ratio of 129.42, a current ratio of 0.25 and a quick ratio of 0.06. The stock’s 50 day simple moving average is C$5.40 and its two-hundred day simple moving average is C$5.18.

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) last issued its quarterly earnings data on Tuesday, November 11th. The company reported C$0.06 EPS for the quarter. NorthWest Health Prop Real Est Inv Trust had a negative net margin of 75.29% and a negative return on equity of 14.67%. The business had revenue of C$110.69 million for the quarter. As a group, research analysts forecast that NorthWest Health Prop Real Est Inv Trust will post 0.4905498 EPS for the current year.

About NorthWest Health Prop Real Est Inv Trust

Northwest Healthcare Properties Real Estate Investment Trust provides investors with access to a portfolio of high-quality healthcare real estate. The company provides investors exposure to a well-diversified portfolio of healthcare real estate located in the greater areas of cities such as Australasia, Brazil, Germany, and Canada of which Australasia derives a majority of revenue to the company.